HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

An autoantibody in narcolepsy disrupts colonic migrating motor complexes.

Abstract
Despite strong circumstantial evidence for the autoimmune hypothesis of narcolepsy, conventional immunological methods have failed to detect an autoantibody. This study investigated the real-time effects of narcoleptic immunoglobulins on a spontaneous colonic migrating motor complex (CMMC) preparation. IgG from patients with narcolepsy with cataplexy or healthy controls was added directly to isolated mouse colons undergoing CMMC activity to test for autoantibodies that disrupt colonic motility. The effect of immunoglobulins prepared for clinical intravenous treatment (IVIg) on autoantibody-mediated colonic disruption was also assessed. Narcoleptic IgGs markedly reduced the frequency of CMMCs or irreversibly abolished them. Abrogation of CMMCs was followed by an increase in the resting tension of the colon preparation and appearance of atropine-sensitive phasic smooth muscle contractions. IVIg partially neutralized the inhibitory effect of narcoleptic IgG on the CMMCs. The dramatic effect of narcoleptic IgG on CMMC generation is consistent with an autoantibody-mediated disruption of enteric neural pathways. The ex vivo whole-organ approach allows real-time examination of the physiological effects of the narcoleptic autoantibody and offers a new avenue for exploring the autoimmune basis of narcolepsy. The neutralizing effect of IVIg on the autoantibody provides a rationale for the reported clinical improvement in cataplexy when IVIg are given at disease onset.
AuthorsMichael W Jackson, Joanne H Reed, Anthony J F Smith, Tom P Gordon
JournalThe Journal of neuroscience : the official journal of the Society for Neuroscience (J Neurosci) Vol. 28 Issue 49 Pg. 13303-9 (Dec 03 2008) ISSN: 1529-2401 [Electronic] United States
PMID19052222 (Publication Type: Journal Article, Research Support, Non-U.S. Gov't)
Chemical References
  • Autoantibodies
  • Immunoglobulins
  • Immunoglobulins, Intravenous
  • Muscarinic Antagonists
  • Atropine
Topics
  • Adult
  • Aged
  • Aged, 80 and over
  • Animals
  • Atropine (pharmacology)
  • Autoantibodies (immunology, toxicity)
  • Colon (drug effects, immunology, physiopathology)
  • Drug Interactions (immunology)
  • Enteric Nervous System (drug effects, immunology, physiopathology)
  • Female
  • Humans
  • Immunoglobulins (immunology, toxicity)
  • Immunoglobulins, Intravenous (pharmacology, therapeutic use)
  • Male
  • Mice
  • Mice, Inbred BALB C
  • Middle Aged
  • Muscarinic Antagonists (pharmacology)
  • Muscle Contraction (drug effects, immunology)
  • Muscle, Smooth (drug effects, immunology, physiopathology)
  • Narcolepsy (drug therapy, immunology, physiopathology)
  • Neuromuscular Junction (drug effects, immunology, physiopathology)
  • Peristalsis (drug effects, immunology)
  • Young Adult

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown: